Exane Derivatives Sol Gel Technologies Ltd. Put Options Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SLGL
# of Institutions
20Shares Held
979KCall Options Held
20.1KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L3247KShares$3.32 Million0.02% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL112KShares$1.51 Million0.0% of portfolio
-
Morgan Stanley New York, NY92.4KShares$1.24 Million0.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL88.5KShares$1.19 Million0.0% of portfolio
-
Menora Mivtachim Holdings Ltd.76.1KShares$1.02 Million0.0% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $311M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...